In this webinar, we explore key considerations and best practices for scaling AAV production, including selecting a transient transfection cell line and sc...

Specific risks associated with SUS integrity assessed as part of the contamination control strategy (CCS).

Unlock advanced approaches to scalable plasmid DNA (pDNA) production in this on-demand webinar, designed for CDMOs and Translational Centers seeking to enh...

As gene therapy moves beyond rare diseases, the gene therapy field faces a common challenge: how to scale AAV manufacturing efficiently. Transient transfec...

Molecular profiling is a powerful approach to understand disease mechanisms, identify biomarkers, and develop targeted therapies in Inflammatory Bowel Dise...

Virus filtration is a robust mechanism to ensure virus safety of biotherapeutic manufacturing processes and must be validated under simulated worst case pr...

Cell and gene therapies are entering a transformative era driven by the need for scalable, cost-effective, and safe gene editing and delivery technologies....

When it comes to cell therapy manufacturing, you’re not just in production. You’re crafting hope for millions awaiting these breakthrough treatments. And e...

This panel discussion was recorded during the Process development virtual summit in June 2025. The discussion is featuring the R&D scientists behind Cytiv...

Discover how Sefia cell therapy manufacturing platform provides flexibility to meet your process needs. In this video, you will see how parameters are open...